Skip to main content
PROTIA INC. logo

PROTIA INC. — Investor Relations & Filings

Ticker · 303360 ISIN · KR7303360002 KO Manufacturing
Filings indexed 246 across all filing types
Latest filing 2024-04-09 Major Shareholding Noti…
Country KR South Korea
Listing KO 303360

PROTIA INC. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells a wide range of diagnostic kits and instruments. The company is particularly known for its flagship product, PROTIA Allergy-Q, a multiplex allergy diagnostic kit for the quantitative determination of allergen-specific IgE. Its portfolio also includes point-of-care testing (POCT) solutions like the ImmuneCheck IgG kit, diagnostic tests for infectious and autoimmune diseases, cancer, and antibiotic susceptibility, as well as the ANITIA line for companion animal allergy testing. In addition to its product offerings, PROTIA provides comprehensive protein analysis services, including LC-MS/MS and characterization analysis, aiming to contribute to early disease prediction and diagnosis through innovative technology.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and the purpose of holding (management influence) for the company 'Protia'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-04-09 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of voting on agenda items such as financial statement approval, director and auditor appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the specific changes in the company's board composition, including the appointment of a new outside director and the resignation of an existing one. This falls under the category of Board/Management Information (MANG), which covers announcements regarding changes in the board of directors.
2024-03-26 Korean
주식매수선택권부여에관한신고
Remuneration Information Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the 'Regulatory Filings' category as it is a specific corporate disclosure requirement that does not fit into the other specialized categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes).
2024-03-26 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official filing titled '정기주주총회결과' (Results of the Annual General Meeting) for the company '프로티아' (Proteia). It details the outcomes of the shareholder meeting held on 2024-03-26, including the approval of financial statements, election of directors and auditors, and dividend resolutions. This document serves as the official record of the voting results and decisions made during the AGM, which falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2024-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, key financial data, and details regarding the auditor, which is characteristic of a standalone audit report filing. While it contains financial data, it is not a full Annual Report (10-K) but rather the specific regulatory disclosure of the audit results as required by Korean market regulations. FY 2023
2024-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.